help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology, doi:10.1210/en.2008-0424
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Romanò, N.
Right arrow Articles by Herbison, A. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Romanò, N.
Right arrow Articles by Herbison, A. E.
Endocrinology Vol. 149, No. 11 5335-5344
Copyright © 2008 by The Endocrine Society

Nonclassical Estrogen Modulation of Presynaptic GABA Terminals Modulates Calcium Dynamics in Gonadotropin-Releasing Hormone Neurons

Nicola Romanò, Kiho Lee, István M. Ábrahám, Christine L. Jasoni and Allan E. Herbison

Centre for Neuroendocrinology and Department of Physiology, University of Otago School of Medical Sciences, Dunedin 9054, New Zealand

Address all correspondence and requests for reprints to: Allan E. Herbison, Centre for Neuroendocrinology, Department of Physiology, University of Otago School of Medical Sciences, P.O. Box 913, Dunedin, New Zealand. E-mail: allan.herbison{at}stonebow.otago.ac.nz.


   Abstract
Top
 Abstract
Introduction
 Materials and Methods
 Results
 Discussion
 References
 
There is increasing recognition that estrogen exerts multifaceted regulatory effects on GnRH neurons. The acute effects of estrogen on calcium dynamics in these cells were examined using a transgenic mouse line that allows real-time measurement of intracellular calcium concentration ([Ca2+]i) in GnRH neurons in the acute brain slice preparation. 17-β-Estradiol (E2) at 100 pM–100 nM was found to activate [Ca2+]i transients in approximately 40% of GnRH neurons with an approximate 15-min latency. This effect was not replicated by E2-BSA, which limits E2 action to the membrane, 17-{alpha}-estradiol, the inactive isomer at classical estrogen receptors (ERs), or G-1 the GPR30 agonist. E2 continued to activate [Ca2+]i transients when transcription was blocked. An ER {alpha}-selective agonist was equally potent in activating [Ca2+]i transients, and E2 remained effective in ERβ knockout x GnRH-Pericam mice. E2’s activation of [Ca2+]i transients continued in the presence of tetrodotoxin, which blocks action potential-dependent transmission, but was abolished completely by the further addition of a {gamma}-aminobutyric acid (GABA)A receptor antagonist. Exogenous GABA was found to initiate [Ca2+]i transients in GnRH neurons. Whole cell, voltage-clamp recordings of GnRH-green fluorescence protein neurons revealed that E2 generated discrete bursts of miniature inhibitory postsynaptic currents with a latency of approximately 15 min. These observations provide evidence for a new mechanism of nonclassical estrogen action within the brain. Estrogen interacts with the classical ER{alpha} at the level of the GABAergic nerve terminal to regulate action potential-independent GABA release that, in turn, controls postsynaptic calcium dynamics.


   Introduction
Top
 Abstract
 Introduction
Materials and Methods
 Results
 Discussion
 References
 
IT IS WELL established that estrogens bind to nuclear-located estrogen receptors (ERs) to modulate gene expression in a classical manner within the brain. It is also now acknowledged that estrogens exert rapid actions on neurons that cannot be attributed to their classical transcriptional effects (1). However, the mechanisms of action underlying these rapid or nonclassical estrogen actions are much less clear. Studies have demonstrated that 17-β-estradiol (E2) can rapidly, within seconds or minutes, modulate ion channel activity and neuronal firing, phosphorylate second messenger signaling molecules, and alter intracellular calcium concentrations ([Ca2+]i) within neurons (for review, see Refs. 2 and 3). This suggests diverse and likely cell-specific modes of nonclassical E2 actions within the brain. Although much controversy surrounds the nature of the estrogen-binding receptors involved in nonclassical actions, it is generally assumed that nonclassical effects are postsynaptic in origin.

One of the most important feedback targets for estrogen in the brain is the GnRH neuronal population. These cells represent the final output neurons of the GnRH neuronal network regulating gonadal function and fertility in all mammals (4, 5). In females, in particular, a complex feedback relationship exists between the cyclical changes in circulating levels of E2 and the secretory behavior of GnRH neurons (6, 7). For the greater part of the ovarian cycle, E2 suppresses the activity of the GnRH neurons. However, at midcycle the high circulating levels of E2 exert a stimulatory action on the GnRH neurons to evoke the GnRH surge that, in turn, initiates ovulation. Whereas it appears that this stimulatory action of E2 on GnRH neurons is mediated by an indirect but nonetheless classical ER{alpha}-dependent mode of estrogen action (8, 9), the mechanisms involved in the suppressive effects are unknown (6, 7). Nonclassical actions of E2 may contribute to estrogen feedback because E2 modulates rapidly the phosphorylation status of intracellular signaling molecules, [Ca2+]i, and the electrical excitability of GnRH neurons (10, 11, 12, 13). Furthermore, it was recently reported that estrogen negative feedback on LH secretion is at least partly dependent upon nonclassical estrogen signaling (9).

In the present study, we used a new transgenic mouse model (14) that enables real-time measurement of [Ca2+]i in GnRH neurons in situ, to examine whether E2 exerts rapid nonclassical effects upon [Ca2+]i dynamics in adult GnRH neurons. These studies have resulted in the identification of a novel mode of nonclassical E2 action that involves the direct presynaptic regulation of action potential-independent {gamma}-aminobutyric acid (GABA) release.


   Materials and Methods
Top
 Abstract
 Introduction
 Materials and Methods
Results
 Discussion
 References
 
Experimental animals
All experimentation was approved by the University of Otago Animal Welfare and Ethics Committee under application 66/02. Transgenic GnRH-Pericam mice (C57BL6/J x CBA/Ca) were maintained under 12-h light, 12-h dark lighting conditions (lights on 0700 h) with food and water available ad libitum. The GnRH-Pericam mice were crossed with ERβ knockout (KO) mice (15) to generate GnRH-Pericam; ERβKO–/– mice that were genotyped by PCR as reported previously (8). The stage of estrous cycle was determined by vaginal smear.

Real-time calcium imaging in GnRH neurons
Calcium imaging experiments were performed as reported previously (14). Briefly, brains were quickly removed from adult (>50 d old) female GnRH-Pericam mice and placed in ice-cold cutting artificial cerebrospinal fluid (ACSF) containing (in mM): 118 NaCl, 3 KCl, 0.5 CaCl2, 6 MgCl2, 5 HEPES, 25 NaHCO3, 11 D-glucose (pH 7.3) when gassed with 95% O2 and 5% CO2. Coronal slices (150-µm thick) cut with a vibratome and kept in a slice chamber mounted in a heated platform (30 ± 2 C) perfused with prewarmed (28–30 C) oxygenated standard ACSF [118 mM NaCl, 3 KCl, 2.5 CaCl2, 1.2 MgCl2, 5 HEPES, 25 NaHCO3, and 11 D-glucose (pH 7.3)] solution at a rate of 1–2 ml/min. Cells were imaged using an Olympus (Tokyo, Japan) BX51 upright microscope. Excitation was alternately performed at 493 and 415 nm every second, and emission filtered at 525 nm with the use of a Sutter Instrument Lambda DG-4 high-speed filter (Sutter Instrument Co., Novato, CA). Image acquisition was performed using MetaFluor (Molecular Devices, Sunnyvale, CA) to control and synchronize the DG-4 and liquid-cooled ORCA-ER CCD camera (Hamamatsu Corp., Hamamatsu City, Shizuoka, Japan). Fluorescence intensity values were exported for a region of interest on the cell and one of the same areas on the background, and analyzed with custom written software (14).

Drugs were tested by addition to the ACSF: E2, 17{alpha}-estradiol, and 6-(O-carboxymethyl)oxime:BSA (E2-6-BSA) (all Sigma-Aldrich Corp., St. Louis, MO); 3,17-dihydroxy-19-nor-17{alpha}-pregna-1,3,5 (10)-triene-21,16{alpha}-lactone (16{alpha}-LE2; kind gift of Bayer-Schering AG, Berlin, Germany); 5,6-dichlorobenzimidazole 1-β-D-ribofuranoside (DRB); and 1-[4-(6-bromobenzo[1, 3]dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinolin-8yl]-ethanone (G-1; kind gift of ChemDiv, Inc., San Diego, CA) were dissolved in ethanol (final concentration ≤ 0.001%). Tetrodotoxin (TTX) (Tocris, Bristol, UK), gabazine (Sigma-Aldrich), 2-aminoethyl diphenylborinate (2-APB) (Sigma-Aldrich), and caffeine (Sigma-Aldrich) were dissolved in water. The E2-6-BSA concentration was calculated considering the molecular mass of BSA plus an average of 35 molecules of E2 per molecule of BSA, giving a total of 75.9 kDa. E2-6-BSA was filtered before use on Microcon YM3 columns (Millipore Corp., Billerica, MA) to remove unconjugated estradiol (11).

Data analysis
The analysis of calcium traces was performed using a Daubechies 4 wavelet transform to detect peaks and baseline changes as reported previously (14). Individual [Ca2+]i transients were considered significant if their heights were at least 10% above baseline (relative power of >15%). The experimental protocol consisted of imaging the cell for 15 min to measure baseline calcium and transient frequency before testing. Initially, 30 cells were imaged for 30 min without any treatment and transient frequency in first 15 min compared with the second 15 min. No significant difference was found in transient frequency between the two periods (mean ± SEM; 0.37 ± 0.10 first period and 0.83 ± 0.24 sec period, n = 30; paired t test). In the case of cells that did not show any transients in the control period, we considered them responsive when they showed more than three transients after the treatment. For cells that had transients in the control period, a more than 3-fold increase in transient frequency was considered a response. All statistical analyses were performed using R software (R development Core Team, http://www. R-project.org) and, unless stated otherwise, involved ANOVA, followed Student-Newman-Keuls post hoc tests.

Whole cell inhibitory postsynaptic current (IPSC) recordings
Acute brain slices (200 µm thick) were made from female GnRH-enhanced green fluorescence protein transgenic mice (6–10 wk old) as described previously for calcium imaging experiments. Whole cell currents were recorded from GnRH neurons at room temperature with the visualization of individual neurons, as reported previously (16). Open resistance was in the range 4–8 M{Omega}, and seal resistance was in the range 1–3 G{Omega}. Patch pipettes were filled with a solution containing (in mM): 140 KCl, 20 HEPES, 0.5 CaCl2, 5 EGTA, and 5 MgATP (pH 7.2). The electrical activity of GnRH neurons was recorded with a headstage (CV-7B) connected with Multiclamp 700A amplifier (Molecular Devices). Current signals were filtered at 1 kHz and digitized at 10 kHz using an analog-digital converter (Digidata 1322A) and pClamp (Version 10.1; Molecular Devices). Upon membrane rupture, GnRH neurons were clamped to –70 mV and allowed to stabilize for 5 min before switching to ACSF (2–3 ml/min) containing 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) (20 µM), DL-2-amino-5-phosphonovaleric acid (AP-5) (20 µM), and TTX (0.5 µM). The experimental protocol was the same as that used for calcium experiments and involved a 15-min pretreatment period, followed by a 15-min exposure to 100 nM E2 or normal ACSF, and then a 15-min washout period. Measurements of the amplitude, frequency, and the decay time of miniature IPSCs (mIPSCs) were performed using the Mini Analysis program (Version 6.0; Synaptosoft Inc., Leonia, NJ). A threshold for detection of mIPSCs was set at 3-fold root mean square noise.


   Results
Top
 Abstract
 Introduction
 Materials and Methods
 Results
Discussion
 References
 
E2 regulates [Ca2+]i dynamics in an acute manner in adult GnRH neurons
As shown previously for adult male GnRH neurons (14), the great majority of GnRH neurons recorded from adult female mice were found to exhibit no or slow transients (less than eight transients per hour). In our initial experiment, GnRH neurons located in the rostral preoptic area of female mice exhibiting less than eight [Ca2+]i transients per hour were tested with an incremental E2 concentration protocol that exposed them to ACSF containing, in sequence, 1, 10, and 100 nM E2 for 15 min each, before returning to the E2-free ACSF (Fig. 1AGo). Of 27 GnRH neurons from 22 mice, 13 (48%) responded by increasing their [Ca2+]i transient frequency. The stimulatory response of individual cells was observed during the 10 or 100 nM E2 treatment period and was prolonged, often continuing throughout the 15-min washout period (Fig. 1Go, A and C). As a group, the increase in [Ca2+]i transient frequency achieved statistical significance during 100 nM E2 and wash period (Fig. 1CGo; P < 0.001; ANOVA). The remaining 14 GnRH neurons did not respond to E2 but were viable because they all responded to a 1- to 2-min exposure to 30 mM caffeine (Fig. 1BGo). The locations of responding and nonresponding GnRH neurons were not different (Fig. 1DGo).


Figure 1
View larger version (34K):
[in this window]
[in a new window]

  		FIG. 1. Estradiol (E2) stimulates calcium transients in GnRH neurons. Note that in all traces, the light gray line represents the actual recording trace and the dark gray line the Daubechies 4 wavelet transform. A, Representative example of a GnRH neuron in which the E2 treatment protocol activated Ca2+ transients. Inset shows a magnification of the three peaks. B, GnRH neuron that was unresponsive to the E2 treatment but responded to 30 mM caffeine (caff). C, Effect of E2 on Ca2+ transient frequency in responding GnRH neurons given as mean + SEM transient frequency over 15-min time bins, including washout period (wash) (n = 13; ***, P < 0.001). D, Schematic diagram of the locations of individual rostral preoptic area GnRH neurons that were stimulated (black dot) or unaffected (gray dot) by E2. Because many GnRH neurons overlap in location, not all cells are shown. AC, Anterior commissure; DBB, diagonal band of Broca; MS, medial septum; vDBB, vertical DBB.

 
Previous studies have demonstrated that interactions may occur between classical and nonclassical E2 actions; specifically, that classical genomic regulation may impact upon the rapid effects of estrogen on neurons (17). However, we found that there was no effect of the stage of estrous cycle upon the ability of E2 to activate [Ca2+]i transients in GnRH neurons. The percent response rate of GnRH neurons to E2 was 50, 55, and 44% in diestrus (n = 11), proestrus (n = 9), and estrous (n = 18) mice, respectively.

In addition to effects of E2 on [Ca2+]i transient frequency, some GnRH neurons also exhibited baseline changes in [Ca2+]i immediately upon application of E2 (Fig. 1AGo). However, there was no relationship between changes in baseline [Ca2+]i and changes in transient frequency, and, overall, no consistent variation in baseline [Ca2+]i was observed.

Dose and time dependency of E2 action upon [Ca2+]i transients
The results of the incremental E2 concentration protocol suggested that the stimulatory response may require many minutes to occur. To address this issue, as well as the concentration dependence of [Ca2+]i activation, experiments were undertaken in which individual GnRH neurons were exposed to single 100 pM, 1 nM, 10 nM, or 100 nM concentrations of E2 for a 15-min period. All concentrations were found to be effective in stimulating [Ca2+]i transients with a common approximate 15-min delay (Fig. 2Go, A and B): 100 pM, three of 13 cells responded with delay 15.4 ± 2.4 min; 1 nM, six of 13 cells responded with delay 13.6 ± 3.0 min; 10 nM, four of eight cells responded with delay 17.9 ± 3.9 min; and 100 nM, six of 13 cells responded with delay 14.7 ± 2.7 min.


Figure 2
View larger version (33K):
[in this window]
[in a new window]

  		FIG. 2. The stimulatory effect of estradiol is mediated by an intracellular receptor and does not involve GPR30. A and B, Representative examples of GnRH neurons responding to 15 min exposure to 100 pM (A) or 100 nM (B) E2. C, Representative example of a GnRH neuron responding to 5 min exposure to 100 nM E2. D and E, Representative traces of GnRH neurons that did not respond to 100 nM E2-6-BSA (D), 100 nM 17{alpha}-estradiol (E), or 100 nM G-1 (F). All of these three cells responded to a caffeine (caf) stimulus at the end of the experiment.

 
The necessity for 15 min of E2 exposure to activate [Ca2+]i transients was tested by treating cells with 100 nM E2 for only 5 min. In this case, three of seven neurons from five animals responded (Fig. 2CGo), and the latency for effect (from the beginning of the E2 exposure; 13.2 ± 1.1 min) was not different from that found with 15-min E2 treatments. These experiments showed that concentrations as low as 100 pM are effective in activating [Ca2+]i transients in GnRH neurons, and that there is an approximate 15-min latency for this effect to occur.

E2 stimulates [Ca2+]i transients in GnRH neurons through an ER{alpha}-dependent mechanism
To evaluate the site and specificity of the E2 effect, GnRH neurons were treated with E2-6-BSA, which limits E2 action to the cell membrane, and 17{alpha}-estradiol, the inactive isomer of E2 at classical ERs. Neither of these compounds, tested at 100 nM concentration for 15 min, had any effects upon [Ca2+]i in GnRH neurons (n = 6 from six animals for E2-6-BSA, seven from seven animals for 17{alpha}-estradiol, Fig. 2Go, D and E), although the cells remained responsive to caffeine (mean ± SEM percent increase in baseline [Ca2+]i; E2 = 15.7 ± 2.5%; 17 {alpha} = 10.4 ± 3.1%; E2-6-BSA = 14.8 ± 1.8%). GPR30 has recently been suggested to be a novel estrogen-binding molecule (18). Application of the GPR30 agonist G-1 [100 nM (19)] did not have any effect on [Ca2+]i in seven GnRH neurons from six animals (Fig. 2FGo).

To evaluate the role of classical ERs in this acute effect, recordings were made from 16 GnRH neurons obtained from 10 GnRH-Pericam+/–; ERβKO–/– mutant mice, and compared with recordings from wild-type and GnRH-Pericam+/–; ERβKO+/+ mice littermates. All genotypes demonstrated the exact same response to E2 (Fig. 3Go, A and C), evoking a significant (P < 0.05) increase in [Ca2+]i transients in 50 and 48% of GnRH neurons from ERβ mutants and controls, respectively. This indicated that ERβ was not required for this response. To address directly the involvement of ER{alpha} in activating [Ca2+]i transients, GnRH neurons from GnRH-Pericam mice were tested with 10 or 100 nM 16{alpha}-LE2, an ER{alpha}-selective ligand with equimolar potency to E2 (20). Application of 10 nM 16{alpha}-LE2 induced [Ca2+]i transients in two of 10 cells (Fig. 3BGo), whereas 100 nM 16{alpha}-LE2 induced [Ca2+]i transients in 10 of 20 cells from 12 animals with a similar pattern to that evoked by 15-min 100 nM E2 (Fig. 3DGo). Together, these data indicated that E2 interacts with ER{alpha} within the cell to initiate calcium transients in GnRH neurons.


Figure 3
View larger version (41K):
[in this window]
[in a new window]

  		FIG. 3. The stimulatory effect of estradiol is mediated by ER-{alpha}. A, Representative trace from a GnRH neuron recorded in an ERβKO x GnRH-Pericam mouse that shows the typical stimulatory response to E2. B, Recording from a GnRH neuron of a GnRH-Pericam mouse that was stimulated by the application of the ER{alpha}-selective agonist 16{alpha}-LE2. C, Mean (+SEM) Ca2+ transient frequency in GnRH-Pericam (Pericam) and GnRH-Pericam x ERβKO mice after exposure to increasing doses of E2 (***, P < 0.001 vs. ACSF). D, Mean (+SEM) Ca2+ transient frequency of GnRH neurons in response to a single dose of 100 nM E2 (gray bars) or the ER-{alpha} selective agonist 16{alpha}-LE2 (black bars) (***, P < 0.001 vs. ACSF). wash, Washout period.

 
E2 acts through a nontranscriptional mechanism to generate [Ca2+]i transients dependent upon inositol-(1,4,5)-triphosphate (IP3) receptors
The 15-min time delay is relatively long for "rapid" estrogen effects and could conceivably result from transcriptional actions. To evaluate this, experiments were performed using the RNA synthesis blocker DRB in a protocol similar to that shown to be effective for mouse olfactory placode GnRH neurons (11). Brain slices were treated with 150 µM DRB 15 min before and during the E2 exposure. Three of seven cells from four animals, treated with 100 nM E2 in the presence of DRB, responded with an activation of [Ca2+]i transients (Fig. 4AGo), indicating that transcription is not necessary for the generation of this response.


Figure 4
View larger version (26K):
[in this window]
[in a new window]

  		FIG. 4. Estradiol activates calcium transients in a transcription-independent mechanism requiring IP3Rs. A, Representative trace from a GnRH neuron showing a response to 100 nM E2 in the presence of 150 µM DRB. B, Representative trace from a GnRH neuron activated by 100 nM E2 in which calcium transients were inhibited by treatment with 100 µM 2-APB. Calcium transients reappeared after removal of 2-APB, and the inhibition was repeatable upon exposure to a second dose of 2-APB. C, Bar graph showing the average (±SEM) frequency of calcium transients in the 15 min preceding 2-APB and during the exposure to 2-APB expressed as percentage of the control period.

 
Previous studies from our laboratory have shown that spontaneous [Ca2+]i transients in GnRH neurons derive from the release of calcium from IP3 receptors (IP3Rs). To test if the same mechanism is involved in the generation of E2-induced transients, five cells that were activated by E2 were treated with the IP3R blocker 2-APB. In four of five cells tested, calcium transients were almost completely suppressed upon treatment with 2-APB (Fig. 4Go, B and C).

E2 activates [Ca2+]i transients in GnRH neurons through a presynaptic mechanism involving GABA
To examine the possibility that E2 acts directly upon GnRH neurons to generate [Ca2+]i transients, experiments were undertaken in the presence of TTX to block action potential-dependent transmission in the brain slice. There were 10 GnRH neurons from seven animals tested with 100 nM E2 in the presence of TTX, and three found to respond in the normal manner with an induction of [Ca2+]i transients (Fig. 5AGo) and a latency of 15.3 ± 2.1 min. This result suggested that E2 may act directly upon GnRH neurons to evoke [Ca2+]i transients but was inconsistent with the known absence of ER{alpha} in these cells (21). Alternatively, it was possible that E2 was influencing action potential-independent neurotransmitter release from nerve terminals synapsing with GnRH neurons. Electrophysiological studies had shown that these neurons are exposed to considerable action potential-independent GABA release (22, 23). Therefore, experiments were repeated with the inclusion of 1 mM gabazine, a GABAA receptor antagonist that (unlike bicuculline) does not fluoresce at the wavelengths used for Pericam recording, and blocks all GABAA receptor-mediated IPSCs in GnRH neurons. In the presence of TTX and gabazine, E2 failed to induce [Ca2+]i transients in all 13 of 13 GnRH neurons from four animals (Fig. 5BGo). This demonstrated that estrogen’s ability to evoke [Ca2+]i transients in GnRH neurons was critically dependent upon presynaptic, action potential-independent GABA release. This predicted that GABA itself would be able to regulate [Ca2+]i in GnRH neurons. Although it is not possible to simulate quantal GABA release, we, nevertheless, tested GnRH neurons with brief (2 min) applications of 50 mM GABA. This was found to evoke a large transient increase in [Ca2+]i in seven of 11 (64%) of GnRH neurons (Fig. 5CGo). Application of 50 mM GABA in the presence of 0.5 mM TTX also induced a large calcium transient in five of six (83%) GnRH neurons.


Figure 5
View larger version (44K):
[in this window]
[in a new window]

  		FIG. 5. The stimulatory effect of estradiol is mediated by action potential-independent GABA release and can be activated by exogenous GABA. A, Representative example of a GnRH neuron treated with TTX but continuing to respond to 100 nM E2 in the normal manner. B, GnRH neuron treated with 100 nM E2 in the presence of both TTX and the GABAA receptor antagonist gabazine (GBZ) showing the failure of the cell to be activated by E2. C, Two examples of GnRH neurons (one in the presence of TTX) showing the ability of GABA to evoke a Ca2+ transient. Note difference in time scale from prior recordings. caff, Caffeine.

 
E2 initiates bursts of mIPSCs in GnRH neurons
Together, the previous results indicated that E2 enhances action potential-independent GABA release upon GnRH neurons. To evaluate this hypothesis directly, GABAA receptor currents were recorded in GnRH neurons using whole cell, voltage-clamp electrophysiology in brain slices of adult female GnRH-green fluorescence protein transgenic mice. The exact same TTX-containing experimental protocol as that used in the calcium experiments was used with the exception of the addition of glutamate receptor antagonists CNQX and AP-5 to ensure that only IPSCs were measured. mIPSCs [mean (±SEM) frequency 0.75 + 0.20 Hz; amplitude 29.5 ± 3.3 pA; decay 15.5 ± 0.7 msec, n = 17] were blocked completely by the GABAA-receptor antagonists bicuculline (10 µM) or gabazine (1 µM), demonstrating that they reflect action potential-independent GABA activation of GABAA receptors on GnRH neurons. Remarkably, E2 (100 nM) applied for 15 min resulted in an abrupt burst of IPSCs (frequency 7.3 ± 4.3 Hz; amplitude 41.7 ± 7.5 pA; duration 145 ± 89 sec, decay 13.9 ± 2.2 msec; Fig. 6AGo), with a mean latency of onset of 15.8 ± 1.3 min (range 13–18 min) (Fig. 6AGo) in four of 17 GnRH neurons from 13 animals (24%; Fig. 6Go, C–F). The IPSC frequency and characteristics did not change in the remaining GnRH neurons (Fig. 6BGo).


Figure 6
View larger version (45K):
[in this window]
[in a new window]

  		FIG. 6. Estradiol initiates bursts of mIPSCs. A, Whole cell, voltage-clamp recordings in the presence of TTX and glutamate receptor antagonists CNQX and AP-5 from adult female GnRH neurons over a 45-min period during which 100 nM E2 was administered to the bath for 15 min (bar). An abrupt increase in the frequency and amplitude of mIPSCs occurs 18 min after application of E2, part of which is expanded in the inset. B, Representative example of a GnRH neuron that did not respond to E2, using the same protocol as in A. Top shows actual trace, and bottom shows 30-sec bin histogram of mIPSC frequency. C–F, mIPSC frequency histogram plots from four GnRH neurons that responded to E2 with a delayed burst in mIPSC (*).

 

   Discussion
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
References
 
This study identifies a new mechanism of rapid, nonclassical E2 action in the brain (Fig. 7Go). Estrogens can exert multiple nonclassical actions upon neurons, and, where established, the underlying mechanisms have involved the direct modulation of signaling cascades within the neuron (1, 3, 24). We now show that the presynaptic terminal is also a direct site of rapid E2 action in the brain and that, using the classical ER, it is able to modulate GABA release dynamics that, in turn, controls [Ca2+]i transients in postsynaptic cells.


Figure 7
View larger version (32K):
[in this window]
[in a new window]

  		FIG. 7. Proposed mechanism of presynaptic estrogen action on GnRH neurons. Schematic diagram showing postulated mechanism of nonclassical estradiol modulation of presynaptic GABAergic terminals to control calcium homeostasis in GnRH neurons. Estradiol (E2) binds ER{alpha} located in the presynaptic GABAergic nerve terminals (1 ) to facilitate action potential-independent GABA release (2 ) that acts through GABAA receptors to initiate intracellular calcium transients in an IP3R-dependent manner (3 ).

 
Our initial genetic and pharmacological analyses indicated that ER{alpha} rather than ERβ was essential for the stimulation of [Ca2+]i transients because the ER{alpha} selective ligand 16{alpha}-LE2 (20) was effective while the E2 response was maintained in GnRH-Pericam+/–; ERβKO–/– mice. In confirmation of the involvement of a classical ER, we found that equimolar 17-{alpha}-estradiol did not stimulate [Ca2+]i transients. Furthermore, this effect was unlikely to occur through a plasma membrane receptor because E2-6-BSA was unable to stimulate [Ca2+]i transients. The E2-6-BSA and 17-{alpha}-estradiol results are not technical false negatives because both compounds at these concentrations evoke effects in other assays within the laboratory (unpublished observations). GPR30 has recently been proposed to be a new E2-binding molecule (18), although it is important to note that considerable controversy surrounds the location of GPR30 within cells (25) and even its ability to bind E2 (26). Application of the GPR30 receptor agonist G-1 did not evoke [Ca2+]i transients, suggesting that this receptor is not involved in regulating calcium dynamics in GnRH neurons. Together, these findings reinforce further the concept that classical ERs are often necessary for the nonclassical rapid effects of E2 in the brain (3, 27) and demonstrate that E2 requires intracellular ER{alpha} to stimulate [Ca2+]i transients in GnRH neurons.

Because GnRH neurons do not express ER{alpha} (21), it seemed unlikely that E2 was acting directly on GnRH neurons to modulate [Ca2+]i dynamics. As such, we were surprised to find that E2 induced [Ca2+]i transients in the absence of action potential-dependent transmission. However, GnRH neurons are known to receive substantial action potential-independent GABA transmission (22, 23), and so we speculated that E2 may be acting at the level of presynaptic GABAergic terminals to modulate GABA release that, in turn, controls the frequency of [Ca2+]i transients in GnRH neurons (Fig. 7Go). This hypothesis has been supported by our calcium imaging and electrophysiological observations. First, we show that the ability of E2 to activate [Ca2+]i transients in TTX-treated GnRH neurons is abolished completely by pretreatment with a GABAA receptor antagonist, thereby identifying the necessity of action potential-independent GABA. The role of action potential-independent GABA release in brain function is not yet well understood (28) but clearly shown here to be involved in regulating postsynaptic calcium dynamics. Second, we show that E2 treatment enhances mIPSCs in GnRH neurons, demonstrating that E2 facilitates action potential-independent GABA release directed at these cells. Finally, we show that treatment with exogenous GABA can itself initiate [Ca2+]i transients in GnRH neurons. It is important to note that, as with many characteristics reported for GnRH neurons (5), only a subpopulation of GnRH neurons responds to E2 in this manner. The biological significance and nature of this heterogeneity remain unknown at present.

Precisely how E2-evoked GABA initiates [Ca2+]i transients in GnRH neurons is not yet established. We show that the mechanism is indeed nonclassical because it is not dependent upon gene transcription. We also report that, like spontaneous [Ca2+]i transients (14), E2-GABA-evoked transients are dependent upon IP3Rs. Current studies in the laboratory are investigating this novel mechanism.

There is now good evidence that ER{alpha} is located within dendrites and nerve terminals (29, 30, 31), and that GABA release is modulated by E2 in multiple brain regions, including putative ER{alpha}-expressing GABAergic afferents to the GnRH neurons (32, 33, 34). However, most compelling of all is the recent work by Woolley and colleagues (35), who found that subpopulations of synaptic vesicles in hippocampal GABAergic neurons are associated with ER{alpha}, and that 24-h E2 treatment moved these vesicles toward the synapse. Although using a different E2 protocol, that ultrastructural study appears to have remarkable parallels with our own findings. Brought together, we suggest that E2 acts on ER{alpha}-associated GABA vesicles in terminals presynaptic to GnRH neurons to modulate action potential-independent GABA release (Fig. 7Go). Whereas many nonclassical effects of E2 occur within seconds or a few minutes (3), we note here that the activation of GABA release and subsequent [Ca2+]i transients takes approximately 15 min. The subcellular mechanisms within the GABAergic terminal responsible for this delay are not known but would be compatible with the several minute delay that might be required for mobilization and movement of vesicles to the synaptic cleft.

It is important to note that this is now the third paper to show that estrogen rapidly modulates [Ca2+]i transients in GnRH neurons. The two previous studies have reported on effects of E2 on [Ca2+]i transients in GnRH neurons from embryonic olfactory placode cultures (11, 36). Whereas all three papers show that E2 can stimulate [Ca2+]i transients in GnRH neurons in the presence of TTX, the apparent underlying mechanism is completely different for each preparation. In embryonic monkey GnRH neurons, this involves an E2-binding membrane receptor (36), whereas in early-cultured mouse embryonic GnRH neurons, it requires an intracellular ERβ-mediated transcriptional event (11), and here, in adult mouse GnRH neurons, we report an indirect GABA-mediated mechanism. Whereas differences might be expected in the way E2 modulates embryonic and adult GnRH neurons, it is perhaps surprising to have such a divergence in mechanism of E2 action between embryonic GnRH neurons in the mouse and monkey.

In summary, the present study has identified a mechanism of nonclassical E2 action that targets classical ERs within the presynaptic terminal to modulate action potential-independent GABA release. Changes in action potential-independent GABA release are further shown to have a key role in controlling [Ca2+]i dynamics in GnRH neurons. A similar scenario in which E2 targets glutamatergic nerve terminals to rapidly modulate postsynaptic neurons has been reported recently in the developing brain (37). This expands considerably the horizons of nonclassical E2 regulation of neural function that have, until now, been focused principally upon postsynaptic sites of action.


   Acknowledgments
 
We thank Bayer-Schering AG for the kind gift of 16-{alpha}-LE2 and ChemDiv for the gift of G-1.


   Footnotes
 
This work was supported by the Wellcome Trust, Royal Society of New Zealand Marsden Fund and Health Research Council of New Zealand. I.M.A. was supported by the International Brain Research Organization, an Öveges Scholarship, and Országos Tudományos Kutatási Alapprogramok Grant 047217.

Disclosure Statement: The authors have nothing to disclose.

First Published Online August 14, 2008

See editorial p. 5325.

Abbreviations: 2-APB, 2-Aminoethyl diphenylborinate; ACSF, artificial cerebrospinal fluid; [Ca2+]i, intracellular calcium concentration; CNQX, 6-cyano-7-nitroquinoxaline-2,3-dione; DRB, 5,6-dichlorobenzimidazole 1-β-D-ribofuranoside; E2, 17-β-estradiol; ER, estrogen receptor; E2-6-BSA, 6-(O-carboxymethyl)oxime:BSA; GABA, {gamma}-aminobutyric acid; IPSC, inhibitory postsynaptic current; IP3, inositol-(1,4,5)-triphosphate; IP3R, inositol-(1,4,5)-triphosphate receptor; KO, knockout; mIPSC, miniature inhibitory postsynaptic current; TTX, tetrodotoxin.

Received March 28, 2008.

Accepted for publication August 6, 2008.


   References
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. McEwen BS, Alves SE 1999 Estrogen actions in the central nervous system. Endocr Rev 20:279–307[Abstract/Free Full Text]
  2. Ronnekleiv OK, Kelly MJ 2005 Diversity of ovarian steroid signaling in the hypothalamus. Front Neuroendocrinol 26:65–84[CrossRef][Medline]
  3. Kelly MJ, Levin ER 2001 Rapid actions of plasma membrane estrogen receptors. Trends Endocrinol Metab 12:152–156[CrossRef][Medline]
  4. Levine JE 1997 New concepts of the neuroendocrine regulation of gonadotropin surges in rats. Biol Reprod 56:293–302[Abstract]
  5. Herbison AE 2006 Physiology of the GnRH neuronal network. In: Neill JD, ed. Knobil and Neill’s physiology of reproduction. 3rd ed. Amsterdam: Elsevier; 1415–1482
  6. Herbison AE 1998 Multimodal influence of estrogen upon gonadotropin-releasing hormone neurons. Endocr Rev 19:302–330[Abstract/Free Full Text]
  7. Petersen SL, Ottem EN, Carpenter CD 2003 Direct and indirect regulation of gonadotropin-releasing hormone neurons by estradiol. Biol Reprod 69:1771–1778[Abstract/Free Full Text]
  8. Wintermantel TM, Campbell RE, Porteous R, Bock D, Grone HJ, Todman MG, Korach KS, Greiner E, Perez CA, Schutz G, Herbison AE 2006 Definition of estrogen receptor pathway critical for estrogen positive feedback to gonadotropin-releasing hormone neurons and fertility. Neuron 52:271–280[CrossRef][Medline]
  9. Glidewell-Kenney C, Hurley LA, Pfaff L, Weiss J, Levine JE, Jameson JL 2007 Nonclassical estrogen receptor {alpha} signaling mediates negative feedback in the female mouse reproductive axis. Proc Natl Acad Sci USA 104:8173–8177[Abstract/Free Full Text]
  10. Lagrange AH, Rønnekleiv OK, Kelly MJ 1995 Estradiol-17β and µ-opioid peptides rapidly hyperpolarize GnRH neurons: a cellular mechanism of negative feedback. Endocrinology 136:2341–2344[Abstract]
  11. Temple JL, Laing E, Sunder A, Wray S 2004 Direct action of estradiol on gonadotropin-releasing hormone-1 neuronal activity via a transcription-dependent mechanism. J Neurosci 24:6326–6333[Abstract/Free Full Text]
  12. Abe H, Terasawa E 2005 Firing pattern and rapid modulation of activity by estrogen in primate luteinizing hormone releasing hormone-1 neurons. Endocrinology 146:4312–4320[Abstract/Free Full Text]
  13. Abraham IM, Han K, Todman MG, Korach KS, Herbison AE 2003 Estrogen receptor β mediates rapid estrogen actions on gonadotropin-releasing hormone neurons in vivo. J Neurosci 23:5771–5777[Abstract/Free Full Text]
  14. Jasoni CL, Todman MG, Strumia MM, Herbison AE 2007 Cell type-specific expression of a genetically encoded calcium indicator reveals intrinsic calcium oscillations in adult gonadotropin-releasing hormone neurons. J Neurosci 27:860–867[Abstract/Free Full Text]
  15. Krege JH, Hodgin JB, Couse JF, Enmark E, Warner M, Magler JF, Sar M, Korach KS, Gustafsson JA, Smithies O 1998 Generation and reproductive phenotypes of mice lacking estrogen receptor β. Proc Natl Acad Sci USA 95:15677–15682[Abstract/Free Full Text]
  16. Han SK, Todman MG, Herbison AE 2004 Endogenous GABA release inhibits the firing of adult gonadotropin-releasing hormone neurons. Endocrinology 145:495–499[CrossRef][Medline]
  17. Vasudevan N, Kow LM, Pfaff DW 2001 Early membrane estrogenic effects required for full expression of slower genomic actions in a nerve cell line. Proc Natl Acad Sci USA 98:12267–12271[Abstract/Free Full Text]
  18. Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ER 2005 A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 307:1625–1630[Abstract/Free Full Text]
  19. Bologa CG, Revankar CM, Young SM, Edwards BS, Arterburn JB, Kiselyov AS, Parker MA, Tkachenko SE, Savchuck NP, Sklar LA, Oprea TI, Prossnitz ER 2006 Virtual and biomolecular screening converge on a selective agonist for GPR30. Nat Chem Biol 2:207–212[CrossRef][Medline]
  20. Hegele-Hartung C, Siebel P, Peters O, Kosemund D, Muller G, Hillisch A, Walter A, Kraetzschmar J, Fritzemeier KH 2004 Impact of isotype-selective estrogen receptor agonists on ovarian function. Proc Natl Acad Sci USA 101:5129–5134[Abstract/Free Full Text]
  21. Herbison AE, Pape JR 2001 New evidence for estrogen receptors in gonadotropin-releasing hormone neurons. Front Neuroendocrinol 22:292–308[CrossRef][Medline]
  22. Sim JA, Skynner MJ, Pape J-R, Herbison AE 2000 Late postnatal reorganization of GABAA receptor signalling in native GnRH neurons. Eur J Neurosci 12:3497–3504[CrossRef][Medline]
  23. Christian CA, Moenter SM 2007 Estradiol induces diurnal shifts in GABA transmission to gonadotropin-releasing hormone neurons to provide a neural signal for ovulation. J Neurosci 27:1913–1921[Abstract/Free Full Text]
  24. Kelly MJ, Lagrange AH, Wagner EJ, Rønnekleiv OK 1999 Rapid effects of estrogen to modulate G protein-coupled receptors via activation of protein kinase A and protein kinase C pathways. Steroids 64:64–75[CrossRef][Medline]
  25. Funakoshi T, Yanai A, Shinoda K, Kawano MM, Mizukami Y 2006 G protein-coupled receptor 30 is an estrogen receptor in the plasma membrane. Biochem Biophys Res Commun 346:904–910[CrossRef][Medline]
  26. Otto C, Rohde-Schulz B, Schwarz G, Fuchs I, Klewer M, Brittain D, Langer G, Bader B, Prelle K, Nubbemeyer R, Fritzemeier KH 2008 GPR30 localizes to the endoplasmic reticulum and is not activated by estradiol. Endocrinology 149:3952–3959[Abstract/Free Full Text]
  27. Abraham IM, Todman MG, Korach KS, Herbison AE 2004 Critical in vivo roles for classical estrogen receptors in rapid estrogen actions on intracellular signaling in mouse brain. Endocrinology 145:3055–3061[CrossRef][Medline]
  28. Staley KJ 1999 Quantal GABA release: noise or not? Nat Neurosci 2:494–495[CrossRef][Medline]
  29. Adams MM, Fink SE, Shah RA, Janssen WG, Hayashi S, Milner TA, McEwen BS, Morrison JH 2002 Estrogen and aging affect the subcellular distribution of estrogen receptor-{alpha} in the hippocampus of female rats. J Neurosci 22:3608–3614[Abstract/Free Full Text]
  30. Blaustein JD, Lehman MN, Turcotte JC, Greene G 1992 Estrogen receptors in dendrites and axon terminals in the guinea pig hypothalamus. Endocrinology 131:281–290[Abstract/Free Full Text]
  31. Milner TA, McEwen BS, Hayashi S, Li CJ, Reagan LP, Alves SE 2001 Ultrastructural evidence that hippocampal {alpha} estrogen receptors are located at extranuclear sites. J Comp Neurol 429:355–371[CrossRef][Medline]
  32. Herbison AE 1997 Estrogen regulation of GABA transmission in rat preoptic area. Brain Res Bull 44:321–326[CrossRef][Medline]
  33. Flugge G, Oertel WH, Wuttke W 1986 Evidence for estrogen-receptive GABAergic neurons in the preoptic/anterior hypothalamic area of the rat brain. Neuroendocrinology 43:1–5[Medline]
  34. Ottem EN, Godwin JG, Krishnan S, Petersen SL 2004 Dual-phenotype GABA/glutamate neurons in adult preoptic area: sexual dimorphism and function. J Neurosci 24:8097–8105[Abstract/Free Full Text]
  35. Hart SA, Snyder MA, Smejkalova T, Woolley CS 2007 Estrogen mobilizes a subset of estrogen receptor-{alpha}-immunoreactive vesicles in inhibitory presynaptic boutons in hippocampal CA1. J Neurosci 27:2102–2111[Abstract/Free Full Text]
  36. Abe H, Keen KL, Terasawa E 2008 Rapid action of estrogens on intracellular calcium oscillations in primate luteinizing hormone-releasing hormone-1 neurons. Endocrinology 149:1155–1162[Abstract/Free Full Text]
  37. Schwarz JM, Liang SL, Thompson SM, McCarthy MM 2008 Estradiol induces hypothalamic dendritic spines by enhancing glutamate release: a mechanism for organizational sex differences. Neuron 58:584–598[CrossRef][Medline]



This article has been cited by other articles:


Home page
 J. Physiol.Home page
A. E. Herbison
Rapid actions of oestrogen on gonadotropin-releasing hormone neurons; from fantasy to physiology?
J. Physiol., November 1, 2009; 587(21): 5025 - 5030.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
L. A. Tremere, J. K. Jeong, and R. Pinaud
Estradiol Shapes Auditory Processing in the Adult Brain by Regulating Inhibitory Transmission and Plasticity-Associated Gene Expression
J. Neurosci., May 6, 2009; 29(18): 5949 - 5963.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
Z. Chu, J. Andrade, M. A. Shupnik, and S. M. Moenter
Differential Regulation of Gonadotropin-Releasing Hormone Neuron Activity and Membrane Properties by Acutely Applied Estradiol: Dependence on Dose and Estrogen Receptor Subtype
J. Neurosci., April 29, 2009; 29(17): 5616 - 5627.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
Z. Zhao, C. Park, M. A. McDevitt, C. Glidewell-Kenney, P. Chambon, J. Weiss, J. L. Jameson, and J. E. Levine
p21-Activated kinase mediates rapid estradiol-negative feedback actions in the reproductive axis
PNAS, April 28, 2009; 106(17): 7221 - 7226.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
B. C. Wadas and S. A. Tobet
Unique Estrogenic Mechanisms for Unique Gonadotropin-Releasing Hormone Neurons?
Endocrinology, November 1, 2008; 149(11): 5325 - 5327.
[Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Romanò, N.
Right arrow Articles by Herbison, A. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Romanò, N.
Right arrow Articles by Herbison, A. E.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals